Oncology Activities
Oncology Pharmacy Insights: Challenging Cases in Patient Care With BTK Inhibitors in B-Cell Malignancies
0290-0000-20-110-H01-P
This program will emphasize clinical and safety evidence for approved and emerging BTK inhibitors in the treatment of B-cell malignancies and highlight pharmacists’ roles in prevention and management of treatment-related adverse effects to improve adherence and patient outcomes.
1.00
Examining the Evolving Landscape of Multiple Myeloma and the Pharmacist's Role in Treatment
0290-0000-20-105-H01-P
This program will focus on advancements in MM treatment in the past year and the role of pharmacists within the team to help optimize adherence monitoring plans, manage adverse effects, and evaluate the effectiveness of new and emerging therapeutic approaches.
1.00
.jpg)
An American Journal of Managed Care Supplement: Managed Care Considerations for Navigating Biosimilar and HER2-Directed Therapies for the Treatment of HER2-Positive Breast Cancer
0290-0000-20-062-H03-P
This supplement will identify challenges to evidence-based adoption of trastuzumab biosimilars and other HER2-targeted therapies.
2.00
A Pharmacist's Guide to the Treatment of Triple Negative Breast Cancer
0290-0000-20-042-H01-P
This session will assess evidence for revised guidelines for the treatment of TNBC and provide information on common adverse effects and ways to manage and optimize therapies to provide care for this patient population.
1.00